Deutsche Bank AG Raises Stock Position in Axon Enterprise, Inc $AXON

Deutsche Bank AG lifted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 10.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 407,432 shares of the biotechnology company's stock after purchasing an additional 38,781 shares during the period. Deutsche Bank AG owned 0.51% of Axon Enterprise worth $228,410,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Darwin Wealth Management LLC purchased a new position in Axon Enterprise during the 2nd quarter worth $37,000. Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise during the 4th quarter valued at $28,000. Camelot Portfolios LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth $30,000. AlphaCentric Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth $34,000. Finally, Strive Financial Group LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth $41,000. Institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other news, insider Isaiah Fields sold 2,000 shares of the company's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the transaction, the insider directly owned 52,813 shares of the company's stock, valued at approximately $21,125,200. This represents a 3.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CRO Cameron Brooks sold 1,242 shares of the stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive owned 49,710 shares of the company's stock, valued at approximately $24,855,000. This represents a 2.44% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 68,989 shares of company stock valued at $36,016,932. 4.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AXON has been the subject of several recent research reports. Morgan Stanley boosted their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. The Goldman Sachs Group reiterated a "buy" rating and set a $715.00 price objective on shares of Axon Enterprise in a research note on Thursday, August 6th. UBS Group lifted their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a report on Thursday, August 6th. Citizens Jmp reissued a "market outperform" rating and issued a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday, June 25th. Finally, TD Cowen restated a "buy" rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $730.92.

Axon Enterprise Stock Up 2.6%

NASDAQ:AXON opened at $619.85 on Wednesday. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $794.29. The stock has a market capitalization of $50.36 billion, a P/E ratio of 257.20, a P/E/G ratio of 9.95 and a beta of 1.39. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. The company's 50-day simple moving average is $532.07 and its 200-day simple moving average is $473.93.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the previous year, the business posted $2.12 EPS. Axon Enterprise's revenue was up 35.3% on a year-over-year basis. On average, equities analysts anticipate that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source